Intersect ENT, Inc.
XENTDelisted May 13, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001271214
Intersect ENT, Inc. was delisted on May 13, 2022; its insiders filed their last Form 4 on May 16, 2022; 131 institutions reported holding it in 13F filings for Q1 2022, worth $828.8M in total; no superinvestor held it.
Holders of 5% or more of XENT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Intersect ENT, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Intersect ENT, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Intersect ENT, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | HealthCor Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Artisan Partners Limited Partnership | 13GOld format | – | New | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Intersect ENT, Inc. shares.
No Form 144 notices for Intersect ENT, Inc. are on file.